Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents: Interim Report (2003)

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

APPENDIX AGENDAS FOR INFORMATION-GATHERING MEETINGS 5 Appendix Agendas for Information-Gathering Meetings Meeting I December 16–17, 2002 The National Academy of Sciences Building 2101 Constitution Avenue, NW Washington, DC Monday, December 16, 2002 1:15 p.m. Introductory Remarks Leslie Benet, Ph.D., Chair, Committee on Accelerating the Research,Development, and Acquisition of Medical Countermeasures AgainstBiological Warfare Agents Introductions by Committee Members and Meeting Attendees 1:30 Sponsor Presentation on the Study Charge Carol Linden, Ph.D., Director, Medical Chemical and Biological DefenseResearch Program, U.S. Army Medical Research and Materiel Command Congressional Comment on the Study Charge Mr. Jean Reed, Professional Staff Member, House Armed Services Committee Discussion 2:30 Status of Department of Defense Effort on Accelerating Research, Development, and Acquisition of Medical Countermeasures Anna Johnson-Winegar, Ph.D., Deputy Assistant to the Secretary of Defensefor Chemical and Biological Defense Discussion 3:15 Break 

APPENDIX AGENDAS FOR INFORMATION-GATHERING MEETINGS 6 3:30 CBER Perspective on Opportunities for Accelerating Licensure of Medical Counter-measures for Biowarfare Agents Kathryn Zoon, Ph.D., Director, Center for Biologics Evaluation and Research,Food and Drug Administration Discussion 4:15 CDER Perspective on Opportunities for Accelerating Licensure of Medical Countermeasures for Biowarfare Agents Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research,Food and Drug Administration Discussion 5:00 Adjourn Tuesday, December 17, 2002 8:00 a.m. Breakfast 8:30 Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military IOM Report, September 2002 Stanley Lemon, M.D., Chair, IOM Committee on a Strategy for Minimizing theImpact of Naturally Occurring Infectious Diseases of Military Importance:Vaccine Issues in the U.S. Military Discussion 9:15 DoD Acquisition of Vaccine Production Report to the Deputy Secretary of Defense, December 2000 Gerald V.Quinnan, Jr., M.D., Professor and Chair of Preventive Medicine,Uniformed Services University of the Health Sciences Discussion 10:00 Adjourn 

APPENDIX AGENDAS FOR INFORMATION-GATHERING MEETINGS 7 Meeting II January 14–15, 2003 The National Academies Building 500 Fifth Street, NW Washington, DC Tuesday, January 14, 2003 9:00 a.m. Breakfast 9:30 Introductory Remarks Leslie Benet, Ph.D., Chair, Committee on Accelerating the Research,Development, and Acquisition of Medical Countermeasures AgainstBiological Warfare Agents 9:45 Medical Countermeasures for Biological Warfare Agents Research Carried out at/through the U.S. Army Medical Research and Materiel Command (USAMRMC) Carol Linden, Ph.D., Director, Medical Chemical and Biological DefenseResearch Program, USAMRMC 10:30 Break 10:45 Chemical and Biological Medical Systems (CBMS) (formerly Joint Vaccine Acquisition Program) COL David Danley, Ph.D., Director, CBMS 11:30 DynPort Vaccine Company LLC Michael J.Langford, Ph.D., Senior Vice President and Chief Scientific Officer,DynPort Vaccine Company LLC 12:00 p.m. Working Lunch 12:45 Defense Threat Reduction Agency (DTRA) LTC Keith R.Vesely, D.V.M., Ph.D., Chief, Medical Science and TechnologyDivision, Chemical and Biological Defense Directorate 1:15 Defense Advanced Research Projects Agency (DARPA) John Carney, Ph.D., Unconventional Pathogen Countermeasures Program 1:45 Joint Program Executive Office for the Chemical and Biological Defense Program (JPEO-CBDP) BG Steve Reeves, Program Executive Officer, Chemical and BiologicalDefense 

APPENDIX AGENDAS FOR INFORMATION-GATHERING MEETINGS 8 2:15 Joint Requirements Office for Chemical, Biological, Radiological, and Nuclear (JRO-CBRN) Defense MAJ Ronald Fizer, Joint Requirements Integrator, JRO-CBRN Defense 2:45 Break 3:00 Directed Roundtable Discussion: Representatives of Involved Government and Other Organizations For each category, a set of questions was circulated to direct to the group 3:00 I Basic Research Early Development 3:45 II Transition to Advanced Development 4:30 III Advanced Development Licensure 5:30 Summary and General Discussion 6:00 Adjourn